Cellectar Biosciences, Inc. Basic Shares Outstanding (Weighted Average)
Cellectar Biosciences, Inc. (CLRB) reported Basic Shares Outstanding (Weighted Average) of 12.23 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- Cellectar Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 12.23M shares, a 660.31% increase year-over-year.
- Cellectar Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 4.24M shares, a 176.05% increase year-over-year.
- Cellectar Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 4.11M shares, a 193.90% increase year-over-year.
- Cellectar Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 3.16M shares, a 141.16% increase year-over-year.
- Cellectar Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 2.61M shares, a 113.67% increase from fiscal 2024.
- Cellectar Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 1.22M shares, a 90.01% decline from fiscal 2023.
- Cellectar Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 12.22M shares, a 73.22% increase from fiscal 2022.
- Cellectar Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 7.06M shares, a 27.09% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 12.23M shares 10-Q · filed 2026-08-13 | 8.26M shares 10-Q · filed 2026-08-13 | 6.86M shares derived: average of 3 quarters · filed 2026-08-13 | 5.94M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 4.24M shares 10-Q · filed 2026-05-14 | 4.17M shares derived: average of 2 quarters · filed 2026-05-14 | 3.84M shares derived: average of 3 quarters · filed 2026-05-14 | 3.28M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 4.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 3.64M shares derived: average of 2 quarters · filed 2026-03-04 | 2.96M shares derived: average of 3 quarters · filed 2026-08-13 | 2.61M shares 10-K · filed 2026-03-04 | ||||
| 2025-09-30 | 3.16M shares 10-Q · filed 2025-11-13 | 2.39M shares derived: average of 2 quarters · filed 2026-08-13 | 2.11M shares 10-Q · filed 2025-11-13 | 1.93M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 1.61M shares 10-Q · filed 2026-08-13 | 1.57M shares 10-Q · filed 2026-08-13 | 1.51M shares derived: average of 3 quarters · filed 2026-08-13 | 1.46M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 1.54M shares 10-Q · filed 2026-05-14 | 46.08M shares 10-Q · filed 2025-05-13 | 1.47M shares derived: average of 2 quarters · filed 2026-05-14 | 1.42M shares derived: average of 3 quarters · filed 2026-05-14 | 1.36M shares derived: average of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | 1.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 1.35M shares derived: average of 2 quarters · filed 2026-03-04 | 1.30M shares derived: average of 3 quarters · filed 2026-03-04 | 1.22M shares 10-K · filed 2026-03-04 | 36.62M shares 10-K · filed 2025-03-13 | |||
| 2024-09-30 | 1.31M shares 10-Q · filed 2025-11-13 | 39.34M shares 10-Q · filed 2024-11-18 | 1.25M shares derived: average of 2 quarters · filed 2025-11-13 | 1.16M shares 10-Q · filed 2025-11-13 | 34.85M shares 10-Q · filed 2024-11-18 | 11.73M shares derived: average of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | 1.19M shares 10-Q · filed 2025-08-14 | 35.82M shares 10-Q · filed 2024-10-29 | 1.09M shares 10-Q · filed 2025-08-14 | 32.58M shares 10-Q · filed 2024-10-29 | 15.20M shares derived: average of 3 quarters · filed 2025-08-14 | 14.23M shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 29.35M shares 10-Q · filed 2025-05-13 | 22.20M shares derived: average of 2 quarters · filed 2025-05-13 | 18.57M shares derived: average of 3 quarters · filed 2025-05-13 | 16.74M shares derived: average of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | 15.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | 13.18M shares derived: average of 2 quarters · filed 2025-03-13 | 12.54M shares derived: average of 3 quarters · filed 2025-03-13 | 12.22M shares 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | 11.31M shares 10-Q · filed 2024-11-18 | 11.28M shares derived: average of 2 quarters · filed 2024-11-18 | 11.28M shares 10-Q · filed 2024-11-18 | 10.93M shares derived: average of 4 quarters · filed 2024-11-18 | ||||
| 2023-06-30 | 11.26M shares 10-K/A · filed 2024-10-29 | 11.26M shares 10-K/A · filed 2024-10-29 | 10.80M shares derived: average of 3 quarters · filed 2024-10-29 | 9.63M shares derived: average of 4 quarters · filed 2024-10-29 | ||||
| 2023-03-31 | 11.26M shares 10-K/A · filed 2024-10-29 | 10.58M shares derived: average of 2 quarters · filed 2024-10-29 | 9.09M shares derived: average of 3 quarters · filed 2024-10-29 | 8.34M shares derived: average of 4 quarters · filed 2024-10-29 | ||||
| 2022-12-31 | 9.89M shares derived: 10-K/A 12 month − 10-K/A 9 month · filed 2024-10-29 | 8.00M shares derived: average of 2 quarters · filed 2024-10-29 | 7.37M shares derived: average of 3 quarters · filed 2024-10-29 | 7.06M shares 10-K/A · filed 2024-10-29 | ||||
| 2022-09-30 | 6.11M shares 10-K/A · filed 2024-10-29 | 6.11M shares derived: average of 2 quarters · filed 2024-10-29 | 6.11M shares 10-K/A · filed 2024-10-29 | 6.11M shares derived: average of 4 quarters · filed 2024-10-29 | ||||
| 2022-06-30 | 6.11M shares 10-K/A · filed 2024-10-29 | 6.11M shares 10-K/A · filed 2024-10-29 | 6.11M shares derived: average of 3 quarters · filed 2024-10-29 | 6.08M shares derived: average of 4 quarters · filed 2024-10-29 | ||||
| 2022-03-31 | 6.11M shares 10-K/A · filed 2024-10-29 | 61.10M shares 10-Q · filed 2022-05-10 | 6.11M shares derived: average of 2 quarters · filed 2024-10-29 | 6.07M shares derived: average of 3 quarters · filed 2024-10-29 | 5.87M shares derived: average of 4 quarters · filed 2024-10-29 | |||
| 2021-12-31 | 6.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 6.05M shares derived: average of 2 quarters · filed 2023-03-09 | 5.79M shares derived: average of 3 quarters · filed 2023-03-09 | 5.55M shares 10-K · filed 2023-03-09 | 55.52M shares 10-K · filed 2022-03-21 | |||
| 2021-09-30 | 5.99M shares 10-Q · filed 2022-11-03 | 59.87M shares 10-Q · filed 2021-11-08 | 5.63M shares derived: average of 2 quarters · filed 2022-11-03 | 5.36M shares 10-Q · filed 2022-11-03 | 53.63M shares 10-Q · filed 2021-11-08 | 22.26M shares derived: average of 4 quarters · filed 2022-11-03 | ||
| 2021-06-30 | 5.28M shares 10-Q · filed 2022-08-05 | 5.05M shares 10-Q · filed 2022-08-05 | 27.68M shares derived: average of 3 quarters · filed 2022-08-05 | 27.34M shares derived: average of 4 quarters · filed 2022-08-05 | ||||
| 2021-03-31 | 48.14M shares 10-Q · filed 2022-05-10 | 38.89M shares derived: average of 2 quarters · filed 2022-05-10 | 34.70M shares derived: average of 3 quarters · filed 2022-05-10 | |||||
| 2020-12-31 | 29.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | 27.98M shares derived: average of 2 quarters · filed 2022-03-21 | 19.81M shares 10-K · filed 2022-03-21 | |||||
| 2020-09-30 | 26.33M shares 10-Q · filed 2021-11-08 | 16.54M shares 10-Q · filed 2021-11-08 | ||||||
| 2016-03-31 | 858.11K shares 10-Q · filed 2016-05-12 | |||||||
| 2015-03-31 | 756.28K shares 10-Q · filed 2016-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |